FDA Denies Gambit To Thwart Generic Competition
Make a commentBy Ed Silverman // February 9th, 2012 // 9:16 am
• Pharma Blog » Archives
Janet Woodcock
FDA Commish: COI Rules Should Remain Intact
2 CommentsBy Ed Silverman // February 2nd, 2012 // 12:39 pm
Bob Temple Changes His Role At FDA, Again
2 CommentsBy Ed Silverman // January 30th, 2012 // 4:58 pm
Plan B Decision Means Nobody Wins: Diana Explains
5 CommentsBy Ed Silverman // December 20th, 2011 // 9:00 am
A Debate: Why Aren’t More Drugs Being Approved?
3 CommentsBy Ed Silverman // September 26th, 2011 // 7:14 am
FDA Biosimilar Guidance May Be Here In ‘Days’
Make a commentBy Ed Silverman // September 23rd, 2011 // 5:19 pm
Amphastar Finally Wins FDA Approval For Its Drug
Make a commentBy Ed Silverman // September 19th, 2011 // 1:09 pm
Help Wanted: Experts For FDA Advisory Panels
9 CommentsBy Ed Silverman // August 4th, 2011 // 9:37 am
FDA Risked Its Integrity During Heparin Probe
1 CommentBy Ed Silverman // November 9th, 2010 // 9:17 am